Article
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease.
Neurology - 8 Sept 2009
Pilotto Alberto, Franceschi M, D'Onofrio G, Bizzarro A, Mangialasche F, Cascavilla L, Paris F, Matera M G, Pilotto Andrea, Daniele A, Mecocci P, Masullo C, Dallapiccola B, Seripa D
Abstract excerpt
OBJECTIVE: To evaluate the influence of the single nucleotide polymorphism rs1080985 in the cytochrome P450 2D6 (CYP2D6) gene on the efficacy of donepezil in patients with mild to moderate Alzheimer disease (AD). METHODS: This was a multicenter, prospective cohort study of 127 white patients with AD according to the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
